High Flow Through Nasal Cannula in Stable and Exacerbated Chronic Obstructive Pulmonary Disease Patients.

CONCLUSION: Though evidence of superiority still lacks and further studies are necessary, HFNC might play a role in the treatment of both stable and exacerbated COPD patients.
PMID: 31291880 [PubMed - as supplied by publisher]

Source: Reviews on Recent Clinical Trials - July 9, 2019 Category: Cancer & Oncology Authors: Bruni A, Garofalo E, Cammarota G, Murabito P, Astuto M, Navalesi P, Luzza F, Abenavoli L, Longhini F Tags: Rev Recent Clin Trials Source Type: research